Delivery Order SPE2DB20D3103-SPE2DB25FQ1K5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count packages) with a contract ceiling value of $4,407.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $16,311.04. This competitive, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,121.24 for Carvedilol ER 40 mg capsules (30-count supply) with a firm fixed price structure. This non-set-aside award was issued on August 15, 2025, with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $11,498.68. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is scheduled for completion by August 21, 2025. The award supports pharmaceutical procurement for federal medical needs, with performance occurring at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $1,544.65 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 2, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $4,628.35. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location...
- The Defense Logistics Agency awarded a delivery order valued at $50,589.89 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,982.78 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules in quantities of 30 units. This contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award status. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Carvedilol ER 40 mg capsules in quantities of 30 per unit, with a contract ceiling value of $4,842.98. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $1,455.29. This non-set-aside, competitively awarded contract was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and features firm fixed price terms. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1K5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) valued at $9,341.40 under a firm fixed-price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-competed delivery order. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, holds a significant position as a critical federal vendor for military and veteran healthcare systems. The parent company maintains an extensive portfolio of federal contract awards with DLA covering a broad spectrum of pharmaceutical products including medications for diabetes management, neurological conditions, pain management, and antibiotics. The SPE2DX IDC represents a strategic procurement vehicle enabling the company to supply pharmaceutical products, specialty medications, vaccines, and related medical supplies to support Defense Health Agency operations and other government healthcare systems globally. DLA Troop Support is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with anticipated multiple awards across separate regions, positioning AmerisourceBergen for continued participation in federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/3/25 |